SEI Investments’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
VCM
LCM
P
ACA
FLPIM
SEI Investments's CRDF Position: Q1 2026 in Review
SEI Investments opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 54,685 shares worth $88.6K. The stake represents ﹤0.01% of the portfolio and ranks #3113 among its holdings. This is a return to the name: SEI Investments previously reported a position in CRDF as recently as Q3 2020.
SEI Investments first reported a position in CRDF in Q3 2020 and has held it in 2 quarters since. The position peaked at $637K in Q3 2020. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.
- SEI Investments held 54,685 shares of Cardiff Oncology worth $88.6K as of Q1 2026.
- Cardiff Oncology was a new SEI Investments position in Q1 2026.
- Cardiff Oncology made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #3113 holding.
- SEI Investments first reported a position in Cardiff Oncology in Q3 2020 and has held it in 2 quarters since.
- SEI Investments's Cardiff Oncology position peaked at $637K in Q3 2020.
- 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.